Following a record-breaking 2025 that saw revenues reach the tens of millions, Empress Royalty is now focused on its next...

Bayer's recently published annual report for 2025 delivers an unambiguous message: the legal risks associated with glyphosate continue to overshadow...

Austria's energy conglomerate, OMV, is demonstrating the tangible results of its profound strategic shift. As its traditional oil operations face...

The recent surge in silver prices encountered a pause on Wednesday, as investors stepped back to lock in gains. Earlier...

The U.S. housing sector is approaching a pivotal moment, with all eyes turning to industry leader Lennar Corporation. The company...

First Acceptance has concluded its 2025 fiscal year with a notable increase in profitability, successfully navigating a strategic change in...

Eterna Therapeutics has drawn significant market attention following a substantial insider purchase and the release of an updated corporate strategy....

As we move into March 2026, the clean energy sector is demonstrating notable resilience in the face of broader global...

A notable divergence has emerged in the market's reaction to Lineage's latest financial report. While sell-side analysts maintain a guarded...

The biopharmaceutical firm Helix BioPharma is intensifying its development of highly targeted cancer treatments. Recent data presentations for its CEACAM6-targeting...